|
|
Drug Delivery Technology Asia 2008
Embracing Opportunities from Potential Technologies and Partnerships
29 - 30 October 2008, JW Marriott Hotel Seoul, South Korea
|
Overview
While the pharmaceutical market continue to expand steadily and generate over US$600 billion in 2006, the global drug delivery market has seen rapid growth since year 2000, from an estimated US$26 billion to US$67 billion in 2006!
These figures come as no surprise because current trend in the pharmaceutical industry points to increasing awareness of the importance of introducing delivery technology at the early phase of drug development. IBC’s Drug Delivery Technology Asia aims to provide a platform to examine current trends and latest developments in the drug delivery business as well as potential opportunities for business and partnerships offered to the pharmaceutical and biotechnology companies.
| EVENT HIGHLIGHTS |
| • |
Excellent line up of over 20 international & regional speakers from both the
research and business faculties |
| • |
Expect to meet over 100 representatives from drug delivery, pharma & biotech companies in the region and overseas |
| • |
2 extended plenary discussion of the day to facilitate exchange of knowledge & business strategies |
| • |
2 in-depth masterclass courses for a comprehensive learning experience |
Key conference themes
| Plus! |
POST-CONFERENCE MASTERCLASSES
FRIDAY 31 OCTOBER 2008 |
Masterclass I: Drug Delivery Technologies, Licensing and Patent Strategies: Commercial Perspectives
Masterclass II: Strategic alliance in global drug delivery market |
Masterclasses outline
| Hear From Distinguished Speakers Including: |
| Prof Vincent Lee,
Professor and Director, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong. |
| Dr Moonsup Jeong,
Senior Research Scientist, iopharmaceutical Research Laboratories,
Dong-A Pharm. Co. Ltd., Korea. |
| David Mashaal, Vice President, Global Business Development, SciGen Ltd, Singapore. |
| Dr Himadri Sen,
President R&D (Generics & NDDS) & Global Quality, Ranbaxy Laboratories Ltd., India. |
| Bill Riegler, General Manager-Nusil Asia,
NuSil Technology LLC, USA. |
| Dr Tomas Landh, Director, Strategy and Sourcing & Principal Scientist, Diabetes Research Unit, Novo Nordisk A/S Denmark. |
| Dr Sven Stegemann, Director Global Pharmaceutical Business Development, Capsugel (A division of Pfizer), Belgium. |
| Dr Ashok Omray, Head, Drug Delivery Systems & Assoc. Vice President, USV Ltd, India. |
| Dr Sung Chun Kim, Chief Technical Officer, LG Life Sciences Ltd, Korea. |
| Prof Sei Kwang Hahn, Assistant Professor, Department of Materials Science & Engineering, Pohang University of Science and Technology (POSTECH), Korea. |
| |
|
|
| Organised by |
|
 |
| Supporting Associations |
|
|
|
|
|
|
|
|
|
| Media Partners |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
